Newhouse, United Kingdom

Margaret Jean Huggett

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: N.v. Organon. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret Jean Huggett. Retrieved from https://idiyas.com/inventor/margaret-jean-huggett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Margaret Jean Huggett

Introduction

Margaret Jean Huggett is a notable inventor based in Newhouse, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on 9-azabicyclo[3.3.1]nonane derivatives. Her research has the potential to impact therapeutic applications significantly.

Latest Patents

Margaret holds a patent for a 9-azabicyclo[3.3.1]nonane derivative, which is described in her patent as a compound of formula I. This invention includes various substituents as defined in the specification and claims, along with pharmaceutically acceptable salts or solvates. The patent also covers pharmaceutical compositions that incorporate these derivatives and their therapeutic uses. She has 1 patent to her name.

Career Highlights

Margaret is associated with N.V. Organon, where she has been able to apply her expertise in pharmaceutical innovation. Her work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Margaret has collaborated with notable colleagues, including Susan Elizabeth Napier and Matilda Jane Bingham. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Margaret Jean Huggett's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to inspire future innovations in therapy and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…